Patent ID: 9271984
Filing Date: 2016-03-01
CPC Classification: A61K,A61P

Claim Text:
1. A method for protecting beta cells from cellular death to thereby delay the onset of type 1 diabetes, comprising administering to a patient in need thereof who is at risk of developing type 1 diabetes due to the presence of antibodies characteristic of the disease but who does not have all the symptoms of type 1 diabetes, an effective amount of a triazine derivative selected in the group consisting of 2-amino-3,6-dihydro-4-dimethylamino-6-methyl-1,3,5-triazine, a racemic form, tautomer, enantiomer, diastereoisomer and epimer thereof, and a pharmaceutically acceptable salt thereof thereby delaying the onset of type 1 diabetes by protecting beta cells from cellular death, said patient not having been administered insulin in a range of less than 24 hours before or after administration of the triazine derivative.